FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

A new clinical trial raises concerns about the safety of low doses of cannabidiol (CBD), even as CBD products continue to grow in popularity.

Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, ...

The agency says Juul's benefits as a less harmful alternative for adult smokers outweigh the risks of teen use. It's a major ...

The HHS secretary and four of his advisers earned at least $3.2 million from their work opposing Big Pharma and promoting ...

GSK shares fell more than 6% on Friday to the bottom of Britain's blue-chip index after a U.S. FDA advisory panel recommended ...

Our medical establishment told people to "Stop Trusting the Public Health Establishment". Now, almost no one trusts our ...

The Food and Drug Administration is allowing vaping brand Juul to keep its e-cigarettes on the market, providing relief to a company that has struggled for years after being widely blamed for sparking ...

GSK shares fell more than 6% on Friday after a U.S. FDA advisory panel recommended against approving its blood cancer drug ...

The regulator authorized the company to keep its e-cigarettes on the U.S. market after a federal ban in 2022 had pushed it to ...

The scrutiny over Coke’s sweeteners began Wednesday, when President Donald Trump announced that Atlanta-based Coca-Cola Co.